176 related articles for article (PubMed ID: 27893656)
1. Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis.
Liu Y; Xing Z; Zhan P; Liu H; Ye W; Lv T; Song Y
Medicine (Baltimore); 2016 Nov; 95(47):e5115. PubMed ID: 27893656
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
Luo J; Shen L; Zheng D
Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
Qiu M; Wang J; Xu Y; Ding X; Li M; Jiang F; Xu L; Yin R
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):206-12. PubMed ID: 25339418
[TBL] [Abstract][Full Text] [Related]
4. Pleural effusion as a substitute for tumor tissue in detecting EGFR/ALK mutations in non-small cell lung cancer: A systematic review and meta-analysis.
Pang C; Ma H; Qin J; Wang S; Wan C; Yang T; Shen Y; Wang D
Medicine (Baltimore); 2019 May; 98(18):e15450. PubMed ID: 31045816
[TBL] [Abstract][Full Text] [Related]
5. Insufficiency of peripheral blood as a substitute tissue for detecting EGFR mutations in lung cancer: a meta-analysis.
Li Z; Zhang Y; Bao W; Jiang C
Target Oncol; 2014 Dec; 9(4):381-8. PubMed ID: 24623059
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis.
Chen Z; Liu HB; Yu CH; Wang Y; Wang L; Song Y
PLoS One; 2014; 9(9):e105940. PubMed ID: 25203004
[TBL] [Abstract][Full Text] [Related]
7. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis.
Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A
Sci Rep; 2018 Sep; 8(1):13379. PubMed ID: 30190486
[TBL] [Abstract][Full Text] [Related]
9. Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review.
Hu F; Mao X; Zhang Y; Zheng X; Gu P; Wang H; Zhang X
Onco Targets Ther; 2018; 11():1373-1384. PubMed ID: 29559795
[TBL] [Abstract][Full Text] [Related]
10. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis.
Wu Y; Liu H; Shi X; Song Y
Lung Cancer; 2015 Jun; 88(3):246-53. PubMed ID: 25837799
[TBL] [Abstract][Full Text] [Related]
11. [Detection of circulating tumor cells with chromosomes 7 and 8 polysomy in non-small cell lung cancer and its correlation with epidermal growth factor receptor mutations in cancer tissue].
Jiang XR; Lu J; Gu YJ; Li YL; Zhao SL; Jin ML
Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):447-452. PubMed ID: 33915649
[No Abstract] [Full Text] [Related]
12. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract][Full Text] [Related]
13. The Diagnostic Accuracy of Liquid Biopsy in EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of 40 Studies.
Wang N; Zhang X; Wang F; Zhang M; Sun B; Yin W; Deng S; Wan Y; Lu W
SLAS Technol; 2021 Feb; 26(1):42-54. PubMed ID: 32659150
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of circulating tumor cells for lung cancer: A systematic review and meta-analysis.
Ye Y; Li SL; Wang JJ; Liu B
Medicine (Baltimore); 2019 Mar; 98(12):e14936. PubMed ID: 30896658
[TBL] [Abstract][Full Text] [Related]
15. Tissue or blood: which is more suitable for detection of EGFR mutations in non-small cell lung cancer?
Biaoxue R; Shuanying Y
Int J Biol Markers; 2018 Jan; 33(1):40-48. PubMed ID: 29552976
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis.
Passiglia F; Rizzo S; Rolfo C; Galvano A; Bronte E; Incorvaia L; Listi A; Barraco N; Castiglia M; Calo V; Bazan V; Russo A
Curr Cancer Drug Targets; 2018; 18(7):697-705. PubMed ID: 29521235
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
Zhang Z; Yan S; Cui H; Chen H; Liu J
Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic test accuracy of droplet digital PCR for the detection of EGFR mutation (T790M) in plasma: Systematic review and meta-analysis.
Liao Y; Chen Y; Kou X; Xiao Y; Ye J; Wu A
Clin Chim Acta; 2020 Apr; 503():190-196. PubMed ID: 31805270
[TBL] [Abstract][Full Text] [Related]
19. EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations.
Tang W; Li X; Xie X; Sun X; Liu J; Zhang J; Wang C; Yu J; Xie P
Lung Cancer; 2019 Oct; 136():6-14. PubMed ID: 31421260
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Meta-Analysis of Association between EGFR Mutation Status and Brain Metastases in NSCLC.
Tan L; Wu Y; Ma X; Yan Y; Shao S; Liu J; Ma H; Liu R; Chai L; Ren J
Pathol Oncol Res; 2019 Apr; 25(2):791-799. PubMed ID: 30761450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
